244 results
Page 8 of 13
424B5
9cos008jwd ldnjhjt9m
13 Oct 10
Prospectus supplement for primary offering
12:00am
8-K
ofspzsh 08xe
25 Aug 10
Departure of Directors or Certain Officers
12:00am
424B5
am7f82qmbg61
18 Jun 10
Prospectus supplement for primary offering
12:00am
424B5
9hlli5scb14p7rzpj
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
pq19aon eej
15 Jun 10
Prospectus supplement
12:00am
8-K
EX-99.1
jp1i0jz
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
424B5
87ahgb4xk
28 Apr 10
Prospectus supplement for primary offering
12:00am
424B5
5fqf7khyy 6ub0pju1
19 Feb 10
Prospectus supplement for primary offering
12:00am
424B5
cbbme vq1lrvmx5vw2
17 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
bhxwi u0bxadjr
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.2
y1xybtlz
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.1
brbwhe0 bcj
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
8-K
EX-99.1
5xz9x
11 Sep 09
Other Events
12:00am
8-K
EX-99.1
hmm6q88m
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-99.1
6s1bhkf331yk6go4e4r
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am